Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes.

Kacerovsky M, Brehm A, Chmelik M, Schmid AI, Szendroedi J, Kacerovsky-Bielesz G, Nowotny P, Lettner A, Wolzt M, Jones JG, Roden M.

J Intern Med. 2011 Feb;269(2):189-99. doi: 10.1111/j.1365-2796.2010.02298.x.

2.

Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study.

Schauer IE, Snell-Bergeon JK, Bergman BC, Maahs DM, Kretowski A, Eckel RH, Rewers M.

Diabetes. 2011 Jan;60(1):306-14. doi: 10.2337/db10-0328. Epub 2010 Oct 26.

3.

Insulin is a stronger inducer of insulin resistance than hyperglycemia in mice with type 1 diabetes mellitus (T1DM).

Liu HY, Cao SY, Hong T, Han J, Liu Z, Cao W.

J Biol Chem. 2009 Oct 2;284(40):27090-100. doi: 10.1074/jbc.M109.016675. Epub 2009 Aug 4.

4.

Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.

Defronzo RA.

Diabetes. 2009 Apr;58(4):773-95. doi: 10.2337/db09-9028. No abstract available.

5.

Intensive versus conventional glucose control in critically ill patients.

NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ.

N Engl J Med. 2009 Mar 26;360(13):1283-97. doi: 10.1056/NEJMoa0810625. Epub 2009 Mar 24.

6.

In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs.

Cassese A, Esposito I, Fiory F, Barbagallo AP, Paturzo F, Mirra P, Ulianich L, Giacco F, Iadicicco C, Lombardi A, Oriente F, Van Obberghen E, Beguinot F, Formisano P, Miele C.

J Biol Chem. 2008 Dec 26;283(52):36088-99. doi: 10.1074/jbc.M801698200. Epub 2008 Oct 27.

7.

Protein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes.

Schmitz-Peiffer C, Biden TJ.

Diabetes. 2008 Jul;57(7):1774-83. doi: 10.2337/db07-1769. Review. No abstract available.

8.

Effects of fasting on insulin action and glucose kinetics in lean and obese men and women.

Bergman BC, Cornier MA, Horton TJ, Bessesen DH.

Am J Physiol Endocrinol Metab. 2007 Oct;293(4):E1103-11. Epub 2007 Aug 7.

9.

Deficiencies of cardiovascular risk prediction models for type 1 diabetes.

Zgibor JC, Piatt GA, Ruppert K, Orchard TJ, Roberts MS.

Diabetes Care. 2006 Aug;29(8):1860-5.

PMID:
16873793
10.

Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes.

Björnholm M, Zierath JR.

Biochem Soc Trans. 2005 Apr;33(Pt 2):354-7. Review.

PMID:
15787605
11.

Diabetic retinopathy.

Fong DS, Aiello LP, Ferris FL 3rd, Klein R.

Diabetes Care. 2004 Oct;27(10):2540-53. Review. No abstract available.

PMID:
15451934
12.

Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study.

Dabelea D, Kinney G, Snell-Bergeon JK, Hokanson JE, Eckel RH, Ehrlich J, Garg S, Hamman RF, Rewers M; Coronary Artery Calcification in Type 1 Diabetes Study.

Diabetes. 2003 Nov;52(11):2833-9. Erratum in: Diabetes. 2004 Aug;53(8):2177.

13.

Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes.

Perseghin G, Lattuada G, Danna M, Sereni LP, Maffi P, De Cobelli F, Battezzati A, Secchi A, Del Maschio A, Luzi L.

Am J Physiol Endocrinol Metab. 2003 Dec;285(6):E1174-81. Epub 2003 Aug 21.

14.

Comparison of methods for achieving 24-hour energy balance in a whole-room indirect calorimeter.

Grunwald GK, Melanson EL, Forster JE, Seagle HM, Sharp TA, Hill JO.

Obes Res. 2003 Jun;11(6):752-9.

15.

Diagnosis of fatty liver disease: is biopsy necessary?

Joy D, Thava VR, Scott BB.

Eur J Gastroenterol Hepatol. 2003 May;15(5):539-43. Review.

PMID:
12702913
16.

Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

Evans JL, Goldfine ID, Maddux BA, Grodsky GM.

Diabetes. 2003 Jan;52(1):1-8. Review.

17.

Molecular understanding of hyperglycemia's adverse effects for diabetic complications.

Sheetz MJ, King GL.

JAMA. 2002 Nov 27;288(20):2579-88. Review.

PMID:
12444865
18.

Insulin resistance in type 1 diabetes.

Greenbaum CJ.

Diabetes Metab Res Rev. 2002 May-Jun;18(3):192-200. Review.

PMID:
12112937
19.

Insulin resistance and cardiovascular disease.

Ginsberg HN.

J Clin Invest. 2000 Aug;106(4):453-8. Review. No abstract available.

20.

Cellular mechanisms of insulin resistance.

Shulman GI.

J Clin Invest. 2000 Jul;106(2):171-6. Review. No abstract available.

Supplemental Content

Support Center